Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock. 1990

C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
Department of Physiology and Biophysics, College of Medicine, University of South Florida, Tampa 33612.

Arteriolar sensitivity to norepinephrine is decreased in endotoxin shock, and sympathetic activity appears altered. We have tested involvement of arteriolar opioid receptors in the response to endotoxin. Cremaster muscle arteriolar reactivity of anesthetized rats was studied using videomicroscopy. Escherichia coli endotoxin (6 mg/kg, i.v., LD100) was infused over a 1-hr period. Mean arterial pressure (Pm), frequency/diameter curves of A1, A2, and A3 arterioles to lumbar sympathetic nerve stimulation (1-16 Hz), and plasma velocity were obtained in group I at control, 30 min, and 90 min postendotoxin and in group II at control and during i.v. infusion of the opiate antagonist naltrexone (0.5 mg/kg/min) at 30 and 90 min postendotoxin. Frequency-diameter curves (percentage of control diameter) were significantly (P less than 0.05) shifted to the right postendotoxin in group I indicating reduced response to lumbar sympathetic stimulation or norepinephrine from the nerve terminals. In group II rats receiving naltrexone after endotoxin, the frequency-diameter curves were significantly (P less than 0.05) shifted to the left indicating enhanced vasoconstriction to lumbar sympathetic stimulation in comparison to control and to group I postendotoxin curves. Postendotoxin, Pm and plasma velocities decreased progressively in group I but were not changed from control in group II. Since opiate receptor blockade during endotoxin shock enhances adrenergic responses of arterioles, opiate receptor stimulation appears to suppress adrenergic receptors.

UI MeSH Term Description Entries
D008297 Male Males
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011941 Receptors, Adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction. Adrenergic Receptors,Adrenoceptor,Adrenoceptors,Norepinephrine Receptor,Receptors, Epinephrine,Receptors, Norepinephrine,Adrenergic Receptor,Epinephrine Receptors,Norepinephrine Receptors,Receptor, Adrenergic,Receptor, Norepinephrine
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001160 Arterioles The smallest divisions of the arteries located between the muscular arteries and the capillaries. Arteriole
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 1984, Circulatory shock,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 1986, Acute care,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 1979, Circulatory shock,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 2006, European journal of dermatology : EJD,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
October 1957, The Journal of laboratory and clinical medicine,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 1970, Canadian Medical Association journal,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
November 1960, Circulation research,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
April 2003, Anesthesiology,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
October 1983, Masui. The Japanese journal of anesthesiology,
C H Baker, and E T Sutton, and Z Zhou, and D G Reynolds
January 1980, Circulatory shock,
Copied contents to your clipboard!